Point-of-Care Diagnostics Market Size, Share & Trends Analysis Report by Product Type (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Monitoring Products, Pregnancy & Fertility Testing Products, Coagulation Monitoring Products, Blood Gas & Electrolyte Testing Products, Urinalysis Testing Products, Hematology Testing Products, Others), Technology, Sample Type, Application, End User, Distribution Channel and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035
|
Market Structure & Evolution |
|
|
Segmental Data Insights |
|
|
Demand Trends |
|
|
Competitive Landscape |
|
|
Strategic Development |
|
|
Future Outlook & Opportunities |
|
Point-of-Care Diagnostics Market Size, Share, and Growth
The global point-of-care diagnostics market is experiencing robust growth, with its estimated value of USD 16.3 billion in the year 2025 and USD 35.3 billion by 2035, registering a CAGR of 8% during the forecast period.
Julia Strandberg the Chief Business Leader Connected Care at Royal Philips explained that their system uses AI to combine clinical signals with diagnostic data. The system enables health systems to provide continuous actionable insights which can be accessed at care locations. The solution provides care teams with necessary context which enables them to make earlier patient interventions that will enhance patient results in different care environments.
The global Point-of-Care Diagnostics market experiences rapid growth because diagnostic devices now achieve faster and more precise and dependable results. Abbott introduced its FreeStyle Libre 3 system on October 2025 which operates as a continuous glucose monitoring device to provide actual time glucose measurements and specialized alerts that help protect patients and support their diabetes management efforts.
The rising cases of chronic diseases which include diabetes and cardiovascular disorders and infectious diseases create a greater need for people to access diagnostic tests that provide results at their sites of need. Healthcare providers require advanced systems that maintain accuracy and safety and comply with strict healthcare regulations which include FDA and CE approval standards.
The combination of innovation, regulatory requirements, and growing disease burden is accelerating the market, improving patient outcomes and healthcare efficiency.
The market offers adjacent opportunities through wearable biosensors and their creation of telemedicine platforms and home diagnostic kits that use AI-based analytics. The Point-of-Care Diagnostics market enables manufacturers to grow their business through these segments which provide better patient monitoring capabilities and result in higher revenue.
Point-of-Care Diagnostics Market Dynamics and Trends
Driver: Increasing Regulatory and Healthcare Mandates Driving Adoption of Advanced Point‑of‑Care Diagnostics
-
Regulatory changes that improve access to decentralized rapid testing systems drive growth in the Point-of-Care Diagnostics market. The U.S. Food and Drug Administration and CE marking organizations now approve CLIA-waived diagnostic systems which use artificial intelligence because they allow healthcare workers to deliver immediate test results that doctors can trust.
- In early 2025 Roche received regulatory approval for its cobas® Pulse AI-powered diagnostic platform which provides real-time biomarker analysis to show that healthcare professionals need more compliant point-of-care testing solutions.
- Healthcare facilities worldwide are adopting more effective diagnostic methods which fulfill strict safety and precision requirements because they need to implement rapid detection tests for infectious diseases and continuous monitoring of chronic illnesses at their facilities.
- The demand for on-site testing increases because more people use outpatient and community healthcare services while clinicians and patients require fast dependable tests that meet regulatory standards for result tracking and system compatibility. All these factors are likely to continue to escalate the growth of the point-of-care diagnostics market.
Restraint: Regulatory Complexity and Data Integration Challenges Limiting Rapid Deployment
-
Point-of-Care Diagnostics are rapidly changing due to the use of Artificial Intelligence (AI) and connectivity, improving the accuracy of diagnosis, automating the interpretation of results, and making it possible to share data in real-time.
- Development of small sensors, analyzers that connect to smartphones, and multiplex testing systems that allow for testing of multiple biomarkers in a single run are changing how point-of-care testing will be utilized in a variety of care settings.
- These advancements enable clinicians to provide quicker and more accurate diagnoses at the bedside or in remote locations, which will improve patient care, expand the capabilities of point-of-care testing throughout the world. All these elements are expected to restrict the expansion of the point-of-care diagnostics market.
Opportunity: Decentralized Healthcare, Emerging Markets, and Technology Partnerships
-
The transition to decentralized healthcare systems together with the increasing adoption of point-of-care diagnostic tests in community health centers pharmacies and residential environments creates a major opportunity for growth. The use of fast portable medical devices enables health professionals to make quick decisions while managing diseases at an early stage especially in remote areas that lack laboratory facilities.
- The creation of integrated healthcare solutions between diagnostic equipment manufacturers and digital health companies develops testing systems that operate in real-time while providing data analysis capabilities which improve patient care coordination and create new business opportunities.
- The growing chronic disease problems in developing countries drive higher demand for affordable point-of-care solutions which provide simple user access to medical services while enabling preventive health programs. And thus, is expected to create more opportunities in future for point-of-care diagnostics market.
Key Trend: Integration of AI, Connectivity, and Multiplex Testing Enhancing Clinical Value
-
The main trend in point-of-care diagnostics currently establishes artificial intelligence as the primary technology which combines multiple omics data types that include genomics and proteomics and metabolomics to discover disease biomarkers while enhancing treatment response predictions.
- The companies in technology and biotechnology sectors increasingly adopt artificial intelligence platforms to study complex biological data which helps them achieve faster results in precise drug development.
- The combination of advanced analytics together with multi-omics research and digital health platforms creates a new approach for precision medicine which uses data to inform clinical decisions and design customized treatment plans. Therefore, is expected to influence significant trends in the point-of-care diagnostics market.
Point-of-Care Diagnostics Market Analysis and Segmental Data
Glucose Monitoring Products Dominates Global Point‑of-Care Diagnostics Market amid Rising Diabetes Prevalence and Demand for Remote Monitoring
-
The glucose monitoring product’s dominance results from the increasing worldwide diabetes rates which create a requirement for regular precise glucose measurements in both medical facilities and domestic environments. The implementation of continuous glucose monitoring together with real-time connected wearable devices increases patient participation while enabling medical professionals to conduct remote treatment.
- The development of Bluetooth and smartphone connection together with AI-powered analytics has made devices easier to use while enhancing their diagnostic performance which leads to increased user adoption.
- The distribution of over-the-counter continuous glucose monitors through retail outlets demonstrates how consumer demand has extended beyond typical clinical applications. The approval of next-generation CGM systems by regulatory bodies demonstrates ongoing innovation and dominance in point-of-care diagnostics market.
North America Dominates Point‑of-Care Diagnostics Market amid Advanced Healthcare Infrastructure and High Adoption of Rapid Testing
-
The leadership of North America shows advanced healthcare systems which exist because of its high healthcare spending rate and its complete deployment of point-of-care diagnostic testing throughout all medical facilities which include hospitals and clinics and urgent care centers and home health services.
- The high adoption of rapid testing solutions for chronic and infectious diseases supports swift clinical decision-making and improved patient outcomes. The deployment of new diagnostic technologies happens faster because of strong regulatory systems and reimbursement regulations which enable medical facilities to acquire innovative diagnostic tools designed for regional healthcare requirements.
- The U.S. FDA approved Roche's cobas Liat molecular tests for sexually transmitted infections which received CLIA waiver authorization in January 2025 for expanded point-of-care testing. North America maintains its leadership in point-of-care diagnostics market because of its combination of infrastructure development and technological progress and advantageous regulatory environment.
Point-of-Care Diagnostics Market Ecosystem
The global Point‑of‑Care Diagnostics market is moderately consolidated, led by Tier 1 players like Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, with Tier 2 and 3 firms providing niche solutions regionally. The system receives advantages through two main elements which include dedicated research activities and established distribution systems.
The main points of the value chain consist of two components which include acquiring reagents and consumables and producing portable analyzers that deliver accurate tests with quick access. Abbott expanded its diagnostic portfolio through its Exact Sciences acquisition which took place in December 2025 to strengthen its strategic operations.
Recent Development and Strategic Overview:
-
In October 2025, The Truenat point-of-care molecular testing platform from Molbio Diagnostics extended its testing capabilities to African and Southeast Asian public health programs through the development of rapid tuberculosis and cervical cancer marker detection systems which use battery-operated PCR equipment to enable testing in remote areas of low-resource environments while enhancing disease monitoring and treatment results.
- In December 2025, Visby Medical received up to USD 65 million in funding which the company will use to speed up its development of an innovative at-home sexually transmitted infection point-of-care test that demonstrates growing demand for diagnostic tools which provide laboratory-quality results in non-clinical settings to consumers.
Report Scope
|
Attribute |
Detail |
|
Market Size in 2025 |
USD 16.3 Bn |
|
Market Forecast Value in 2035 |
USD 35.3 Bn |
|
Growth Rate (CAGR) |
8% |
|
Forecast Period |
2025 – 2035 |
|
Historical Data Available for |
2020 – 2024 |
|
Market Size Units |
USD Billion for Value |
|
Report Format |
Electronic (PDF) + Excel |
|
Regions and Countries Covered |
|||||
|
North America |
Europe |
Asia Pacific |
Middle East |
Africa |
South America |
|
|
|
|
|
|
|
Companies Covered |
|||||
|
|
|
|
|
|
Point-of-Care Diagnostics Market Segmentation and Highlights
|
Segment |
Sub-segment |
|
Point-of-Care Diagnostics Market, By Product Type |
|
|
Point-of-Care Diagnostics Market, By Technology |
|
|
Point-of-Care Diagnostics Market, By Sample Type |
|
|
Point-of-Care Diagnostics Market, By Application |
|
|
Point-of-Care Diagnostics Market, By End User |
|
|
Point-of-Care Diagnostics Market, By Distribution Channel |
|
Frequently Asked Questions
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Natures
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Natures
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Global Point-of-Care Diagnostics Market Outlook
- 2.1.1. Point-of-Care Diagnostics Market Size (Value - US$ Bn), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End-use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2026-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. Global Point-of-Care Diagnostics Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
- 3.1.1. Healthcare & Pharmaceutical Industry Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Rising prevalence of chronic and infectious diseases driving demand for rapid, on-site diagnostics.
- 4.1.1.2. Technological advancements, including AI-enabled, wearable, and connected diagnostic devices.
- 4.1.1.3. Growing adoption of decentralized and home-based healthcare solutions.
- 4.1.2. Restraints
- 4.1.2.1. High cost and complexity of integrating POC devices with existing healthcare IT systems.
- 4.1.2.2. Stringent regulatory requirements and lengthy approval processes for new diagnostic devices.
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global Point-of-Care Diagnostics Market Demand
- 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
- 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
- 4.7.2.1. Y-o-Y Growth Trends
- 4.7.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. Global Point-of-Care Diagnostics Market Analysis, by Product Type
- 6.1. Key Segment Analysis
- 6.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
- 6.2.1. Glucose Monitoring Products
- 6.2.1.1. Blood Glucose Meters
- 6.2.1.2. Continuous Glucose Monitoring Systems
- 6.2.1.3. Test Strips & Lancets
- 6.2.1.4. Others
- 6.2.2. Infectious Disease Testing Products
- 6.2.2.1. Rapid Antigen Tests
- 6.2.2.2. Molecular Diagnostic POC Tests
- 6.2.2.3. Antibody-based Tests
- 6.2.2.4. Others
- 6.2.3. Cardiometabolic Monitoring Products
- 6.2.3.1. Cholesterol Testing Kits
- 6.2.3.2. HbA1c Testing Devices
- 6.2.3.3. Lipid Profile Testing Devices
- 6.2.3.4. Others
- 6.2.4. Pregnancy & Fertility Testing Products
- 6.2.4.1. Pregnancy Test Kits
- 6.2.4.2. Ovulation Test Kits
- 6.2.4.3. Others
- 6.2.5. Coagulation Monitoring Products
- 6.2.5.1. Prothrombin Time Testing Devices
- 6.2.5.2. INR Monitoring Systems
- 6.2.5.3. Others
- 6.2.6. Blood Gas & Electrolyte Testing Products
- 6.2.7. Urinalysis Testing Products
- 6.2.8. Hematology Testing Products
- 6.2.9. Others
- 6.2.1. Glucose Monitoring Products
- 7. Global Point-of-Care Diagnostics Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
- 7.2.1. Lateral Flow Assays
- 7.2.2. Immunoassays
- 7.2.3. Molecular Diagnostics
- 7.2.3.1. PCR-based Testing
- 7.2.3.2. Isothermal Nucleic Acid Amplification
- 7.2.3.3. Others
- 7.2.4. Biosensor-based Diagnostics
- 7.2.5. Microfluidics-based Diagnostics
- 7.2.6. Lab-on-a-Chip Technologies
- 7.2.7. Others
- 8. Global Point-of-Care Diagnostics Market Analysis, by Sample Type
- 8.1. Key Segment Analysis
- 8.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Sample Type, 2021-2035
- 8.2.1. Blood
- 8.2.2. Urine
- 8.2.3. Saliva
- 8.2.4. Nasal & Nasopharyngeal Swabs
- 8.2.5. Stool Samples
- 8.2.6. Other Body Fluids
- 9. Global Point-of-Care Diagnostics Market Analysis, by Application
- 9.1. Key Segment Analysis
- 9.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
- 9.2.1. Infectious Diseases
- 9.2.1.1. COVID-19
- 9.2.1.2. Influenza
- 9.2.1.3. HIV
- 9.2.1.4. Hepatitis
- 9.2.1.5. Tuberculosis
- 9.2.1.6. Others
- 9.2.2. Diabetes Management
- 9.2.3. Cardiovascular Diseases
- 9.2.4. Oncology
- 9.2.5. Respiratory Diseases
- 9.2.6. Pregnancy & Fertility Testing
- 9.2.7. Metabolic Disorders
- 9.2.8. Others
- 9.2.1. Infectious Diseases
- 10. Global Point-of-Care Diagnostics Market Analysis, by End User
- 10.1. Key Segment Analysis
- 10.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by End User, 2021-2035
- 10.2.1. Hospitals & Clinics
- 10.2.2. Diagnostic Laboratories
- 10.2.3. Home Care Settings
- 10.2.4. Ambulatory Care Centers
- 10.2.5. Physician Offices
- 10.2.6. Research Institutes
- 10.2.7. Others
- 11. Global Point-of-Care Diagnostics Market Analysis, by Distribution Channel
- 11.1. Key Segment Analysis
- 11.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Distribution Channel, 2021-2035
- 11.2.1. Hospital Pharmacies
- 11.2.2. Retail Pharmacies
- 11.2.3. Online Pharmacies
- 11.2.4. Direct Sales to Healthcare Facilities
- 11.2.5. Others
- 12. Global Point-of-Care Diagnostics Market Analysis and Forecasts, by Region
- 12.1. Key Findings
- 12.2. Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
- 12.2.1. North America
- 12.2.2. Europe
- 12.2.3. Asia Pacific
- 12.2.4. Middle East
- 12.2.5. Africa
- 12.2.6. South America
- 13. North America Point-of-Care Diagnostics Market Analysis
- 13.1. Key Segment Analysis
- 13.2. Regional Snapshot
- 13.3. North America Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 13.3.1. Product Type
- 13.3.2. Technology
- 13.3.3. Sample Type
- 13.3.4. Application
- 13.3.5. End User
- 13.3.6. Distribution Channel
- 13.3.7. Country
- 13.3.7.1. USA
- 13.3.7.2. Canada
- 13.3.7.3. Mexico
- 13.4. USA Point-of-Care Diagnostics Market
- 13.4.1. Country Segmental Analysis
- 13.4.2. Product Type
- 13.4.3. Technology
- 13.4.4. Sample Type
- 13.4.5. Application
- 13.4.6. End User
- 13.4.7. Distribution Channel
- 13.5. Canada Point-of-Care Diagnostics Market
- 13.5.1. Country Segmental Analysis
- 13.5.2. Product Type
- 13.5.3. Technology
- 13.5.4. Sample Type
- 13.5.5. Application
- 13.5.6. End User
- 13.5.7. Distribution Channel
- 13.6. Mexico Point-of-Care Diagnostics Market
- 13.6.1. Country Segmental Analysis
- 13.6.2. Product Type
- 13.6.3. Technology
- 13.6.4. Sample Type
- 13.6.5. Application
- 13.6.6. End User
- 13.6.7. Distribution Channel
- 14. Europe Point-of-Care Diagnostics Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. Europe Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 14.3.1. Product Type
- 14.3.2. Technology
- 14.3.3. Sample Type
- 14.3.4. Application
- 14.3.5. End User
- 14.3.6. Distribution Channel
- 14.3.7. Country
- 14.3.7.1. Germany
- 14.3.7.2. United Kingdom
- 14.3.7.3. France
- 14.3.7.4. Italy
- 14.3.7.5. Spain
- 14.3.7.6. Netherlands
- 14.3.7.7. Nordic Countries
- 14.3.7.8. Poland
- 14.3.7.9. Russia & CIS
- 14.3.7.10. Rest of Europe
- 14.4. Germany Point-of-Care Diagnostics Market
- 14.4.1. Country Segmental Analysis
- 14.4.2. Product Type
- 14.4.3. Technology
- 14.4.4. Sample Type
- 14.4.5. Application
- 14.4.6. End User
- 14.4.7. Distribution Channel
- 14.5. United Kingdom Point-of-Care Diagnostics Market
- 14.5.1. Country Segmental Analysis
- 14.5.2. Product Type
- 14.5.3. Technology
- 14.5.4. Sample Type
- 14.5.5. Application
- 14.5.6. End User
- 14.5.7. Distribution Channel
- 14.6. France Point-of-Care Diagnostics Market
- 14.6.1. Country Segmental Analysis
- 14.6.2. Product Type
- 14.6.3. Technology
- 14.6.4. Sample Type
- 14.6.5. Application
- 14.6.6. End User
- 14.6.7. Distribution Channel
- 14.7. Italy Point-of-Care Diagnostics Market
- 14.7.1. Country Segmental Analysis
- 14.7.2. Product Type
- 14.7.3. Technology
- 14.7.4. Sample Type
- 14.7.5. Application
- 14.7.6. End User
- 14.7.7. Distribution Channel
- 14.8. Spain Point-of-Care Diagnostics Market
- 14.8.1. Country Segmental Analysis
- 14.8.2. Product Type
- 14.8.3. Technology
- 14.8.4. Sample Type
- 14.8.5. Application
- 14.8.6. End User
- 14.8.7. Distribution Channel
- 14.9. Netherlands Point-of-Care Diagnostics Market
- 14.9.1. Country Segmental Analysis
- 14.9.2. Product Type
- 14.9.3. Technology
- 14.9.4. Sample Type
- 14.9.5. Application
- 14.9.6. End User
- 14.9.7. Distribution Channel
- 14.10. Nordic Countries Point-of-Care Diagnostics Market
- 14.10.1. Country Segmental Analysis
- 14.10.2. Product Type
- 14.10.3. Technology
- 14.10.4. Sample Type
- 14.10.5. Application
- 14.10.6. End User
- 14.10.7. Distribution Channel
- 14.11. Poland Point-of-Care Diagnostics Market
- 14.11.1. Country Segmental Analysis
- 14.11.2. Product Type
- 14.11.3. Technology
- 14.11.4. Sample Type
- 14.11.5. Application
- 14.11.6. End User
- 14.11.7. Distribution Channel
- 14.12. Russia & CIS Point-of-Care Diagnostics Market
- 14.12.1. Country Segmental Analysis
- 14.12.2. Product Type
- 14.12.3. Technology
- 14.12.4. Sample Type
- 14.12.5. Application
- 14.12.6. End User
- 14.12.7. Distribution Channel
- 14.13. Rest of Europe Point-of-Care Diagnostics Market
- 14.13.1. Country Segmental Analysis
- 14.13.2. Product Type
- 14.13.3. Technology
- 14.13.4. Sample Type
- 14.13.5. Application
- 14.13.6. End User
- 14.13.7. Distribution Channel
- 15. Asia Pacific Point-of-Care Diagnostics Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Asia Pacific Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 15.3.1. Product Type
- 15.3.2. Technology
- 15.3.3. Sample Type
- 15.3.4. Application
- 15.3.5. End User
- 15.3.6. Distribution Channel
- 15.3.7. Country
- 15.3.7.1. China
- 15.3.7.2. India
- 15.3.7.3. Japan
- 15.3.7.4. South Korea
- 15.3.7.5. Australia and New Zealand
- 15.3.7.6. Indonesia
- 15.3.7.7. Malaysia
- 15.3.7.8. Thailand
- 15.3.7.9. Vietnam
- 15.3.7.10. Rest of Asia Pacific
- 15.4. China Point-of-Care Diagnostics Market
- 15.4.1. Country Segmental Analysis
- 15.4.2. Product Type
- 15.4.3. Technology
- 15.4.4. Sample Type
- 15.4.5. Application
- 15.4.6. End User
- 15.4.7. Distribution Channel
- 15.5. India Point-of-Care Diagnostics Market
- 15.5.1. Country Segmental Analysis
- 15.5.2. Product Type
- 15.5.3. Technology
- 15.5.4. Sample Type
- 15.5.5. Application
- 15.5.6. End User
- 15.5.7. Distribution Channel
- 15.6. Japan Point-of-Care Diagnostics Market
- 15.6.1. Country Segmental Analysis
- 15.6.2. Product Type
- 15.6.3. Technology
- 15.6.4. Sample Type
- 15.6.5. Application
- 15.6.6. End User
- 15.6.7. Distribution Channel
- 15.7. South Korea Point-of-Care Diagnostics Market
- 15.7.1. Country Segmental Analysis
- 15.7.2. Product Type
- 15.7.3. Technology
- 15.7.4. Sample Type
- 15.7.5. Application
- 15.7.6. End User
- 15.7.7. Distribution Channel
- 15.8. Australia and New Zealand Point-of-Care Diagnostics Market
- 15.8.1. Country Segmental Analysis
- 15.8.2. Product Type
- 15.8.3. Technology
- 15.8.4. Sample Type
- 15.8.5. Application
- 15.8.6. End User
- 15.8.7. Distribution Channel
- 15.9. Indonesia Point-of-Care Diagnostics Market
- 15.9.1. Country Segmental Analysis
- 15.9.2. Product Type
- 15.9.3. Technology
- 15.9.4. Sample Type
- 15.9.5. Application
- 15.9.6. End User
- 15.9.7. Distribution Channel
- 15.10. Malaysia Point-of-Care Diagnostics Market
- 15.10.1. Country Segmental Analysis
- 15.10.2. Product Type
- 15.10.3. Technology
- 15.10.4. Sample Type
- 15.10.5. Application
- 15.10.6. End User
- 15.10.7. Distribution Channel
- 15.11. Thailand Point-of-Care Diagnostics Market
- 15.11.1. Country Segmental Analysis
- 15.11.2. Product Type
- 15.11.3. Technology
- 15.11.4. Sample Type
- 15.11.5. Application
- 15.11.6. End User
- 15.11.7. Distribution Channel
- 15.12. Vietnam Point-of-Care Diagnostics Market
- 15.12.1. Country Segmental Analysis
- 15.12.2. Product Type
- 15.12.3. Technology
- 15.12.4. Sample Type
- 15.12.5. Application
- 15.12.6. End User
- 15.12.7. Distribution Channel
- 15.13. Rest of Asia Pacific Point-of-Care Diagnostics Market
- 15.13.1. Country Segmental Analysis
- 15.13.2. Product Type
- 15.13.3. Technology
- 15.13.4. Sample Type
- 15.13.5. Application
- 15.13.6. End User
- 15.13.7. Distribution Channel
- 16. Middle East Point-of-Care Diagnostics Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Middle East Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 16.3.1. Product Type
- 16.3.2. Technology
- 16.3.3. Sample Type
- 16.3.4. Application
- 16.3.5. End User
- 16.3.6. Distribution Channel
- 16.3.7. Country
- 16.3.7.1. Turkey
- 16.3.7.2. UAE
- 16.3.7.3. Saudi Arabia
- 16.3.7.4. Israel
- 16.3.7.5. Rest of Middle East
- 16.4. Turkey Point-of-Care Diagnostics Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Product Type
- 16.4.3. Technology
- 16.4.4. Sample Type
- 16.4.5. Application
- 16.4.6. End User
- 16.4.7. Distribution Channel
- 16.5. UAE Point-of-Care Diagnostics Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Product Type
- 16.5.3. Technology
- 16.5.4. Sample Type
- 16.5.5. Application
- 16.5.6. End User
- 16.5.7. Distribution Channel
- 16.6. Saudi Arabia Point-of-Care Diagnostics Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Product Type
- 16.6.3. Technology
- 16.6.4. Sample Type
- 16.6.5. Application
- 16.6.6. End User
- 16.6.7. Distribution Channel
- 16.7. Israel Point-of-Care Diagnostics Market
- 16.7.1. Country Segmental Analysis
- 16.7.2. Product Type
- 16.7.3. Technology
- 16.7.4. Sample Type
- 16.7.5. Application
- 16.7.6. End User
- 16.7.7. Distribution Channel
- 16.8. Rest of Middle East Point-of-Care Diagnostics Market
- 16.8.1. Country Segmental Analysis
- 16.8.2. Product Type
- 16.8.3. Technology
- 16.8.4. Sample Type
- 16.8.5. Application
- 16.8.6. End User
- 16.8.7. Distribution Channel
- 17. Africa Point-of-Care Diagnostics Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Africa Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 17.3.1. Product Type
- 17.3.2. Technology
- 17.3.3. Sample Type
- 17.3.4. Application
- 17.3.5. End User
- 17.3.6. Distribution Channel
- 17.3.7. Country
- 17.3.7.1. South Africa
- 17.3.7.2. Egypt
- 17.3.7.3. Nigeria
- 17.3.7.4. Algeria
- 17.3.7.5. Rest of Africa
- 17.4. South Africa Point-of-Care Diagnostics Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Product Type
- 17.4.3. Technology
- 17.4.4. Sample Type
- 17.4.5. Application
- 17.4.6. End User
- 17.4.7. Distribution Channel
- 17.5. Egypt Point-of-Care Diagnostics Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Product Type
- 17.5.3. Technology
- 17.5.4. Sample Type
- 17.5.5. Application
- 17.5.6. End User
- 17.5.7. Distribution Channel
- 17.6. Nigeria Point-of-Care Diagnostics Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Product Type
- 17.6.3. Technology
- 17.6.4. Sample Type
- 17.6.5. Application
- 17.6.6. End User
- 17.6.7. Distribution Channel
- 17.7. Algeria Point-of-Care Diagnostics Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Product Type
- 17.7.3. Technology
- 17.7.4. Sample Type
- 17.7.5. Application
- 17.7.6. End User
- 17.7.7. Distribution Channel
- 17.8. Rest of Africa Point-of-Care Diagnostics Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Product Type
- 17.8.3. Technology
- 17.8.4. Sample Type
- 17.8.5. Application
- 17.8.6. End User
- 17.8.7. Distribution Channel
- 18. South America Point-of-Care Diagnostics Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. South America Point-of-Care Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
- 18.3.1. Product Type
- 18.3.2. Technology
- 18.3.3. Sample Type
- 18.3.4. Application
- 18.3.5. End User
- 18.3.6. Distribution Channel
- 18.3.7. Country
- 18.3.7.1. Brazil
- 18.3.7.2. Argentina
- 18.3.7.3. Rest of South America
- 18.4. Brazil Point-of-Care Diagnostics Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Product Type
- 18.4.3. Technology
- 18.4.4. Sample Type
- 18.4.5. Application
- 18.4.6. End User
- 18.4.7. Distribution Channel
- 18.5. Argentina Point-of-Care Diagnostics Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Product Type
- 18.5.3. Technology
- 18.5.4. Sample Type
- 18.5.5. Application
- 18.5.6. End User
- 18.5.7. Distribution Channel
- 18.6. Rest of South America Point-of-Care Diagnostics Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Product Type
- 18.6.3. Technology
- 18.6.4. Sample Type
- 18.6.5. Application
- 18.6.6. End User
- 18.6.7. Distribution Channel
- 19. Key Players/ Company Profile
- 19.1. Abbott Laboratories
- 19.1.1. Company Details/ Overview
- 19.1.2. Company Financials
- 19.1.3. Key Customers and Competitors
- 19.1.4. Business/ Industry Portfolio
- 19.1.5. Product Portfolio/ Specification Details
- 19.1.6. Pricing Data
- 19.1.7. Strategic Overview
- 19.1.8. Recent Developments
- 19.2. Becton, Dickinson and Company
- 19.3. bioMérieux S.A.
- 19.4. Bio-Rad Laboratories, Inc.
- 19.5. Chembio Diagnostics, Inc.
- 19.6. Danaher Corporation
- 19.7. EKF Diagnostics Holdings plc
- 19.8. F. Hoffmann-La Roche Ltd.
- 19.9. Nova Biomedical Corporation
- 19.10. OraSure Technologies, Inc.
- 19.11. PTS Diagnostics
- 19.12. QIAGEN N.V.
- 19.13. QuidelOrtho Corporation
- 19.14. Sekisui Diagnostics, LLC
- 19.15. Siemens Healthineers AG
- 19.16. Sysmex Corporation
- 19.17. Thermo Fisher Scientific Inc.
- 19.18. Trinity Biotech plc
- 19.19. Trividia Health, Inc.
- 19.20. Werfen S.A.
- 19.21. Other Key Players
- 19.1. Abbott Laboratories
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
Research Design
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
Research Approach
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
Research Methods
Desk / Secondary Research
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is a combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase, and others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players' product portfolio
Primary Research
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources include primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
Forecasting Factors and Models
Forecasting Factors
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Forecasting Models / Techniques
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Research Analysis
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Validation & Evaluation
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
Custom Market Research Services
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation